跳至主要内容
临床试验/NCT02702674
NCT02702674Unknown3 期

The Effect of Coadministration of Oral Propranolol to Oxytocin on Induction of Labor

Ain Shams Maternity Hospital1 个研究点 分布在 1 个国家目标入组 242 人开始时间: 2015年12月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
入组人数
242
试验地点
1
主要终点
duration of first stage of labour

研究概览

简要总结

The effect of coadministration of oral propranolol to oxytocin on induction of labor.

详细描述

Study hypothesis:

Oral propranolol when used with oxytocin during the process of labor may reduce labor interval and decrease the rate of cesarean delivery.

Study population:

The patients will be recruited from the women attending obstetrics reception room, in Ain Shams University Maternity Hospital.

Intervention:

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Care Provider)

入排标准

年龄范围
17 Years 至 40 Years(Child, Adult)
性别
Female
接受健康志愿者

入选标准

  • Gestational age above 37 weeks.
  • Fetal life positive on ultrasound.
  • Bishop score >
  • Primiparous women.

排除标准

  • history of uterine surgery
  • polyhydramnios
  • contraindications to β-adrenergic agents, such as systolic blood pressure less than 100 mmHg or pulse rate less than 60/min and more than 120/min
  • history of any known cardiac disease
  • mother's pulmonary or metabolic disorders
  • fetal distress
  • estimated weight of the fetus more than 4 kg by ultrasound of cephalic presentation

研究组 & 干预措施

propranolol plus oxytocin

Active Comparator

121 patients who will receive a capsule containing 20 mg propranolol (propranolol plus oxytocin) administrated orally before beginning induction and repeated after 8 hours if no sufficient uterine contractions reached.

干预措施: propranolol (Drug)

propranolol plus oxytocin

Active Comparator

121 patients who will receive a capsule containing 20 mg propranolol (propranolol plus oxytocin) administrated orally before beginning induction and repeated after 8 hours if no sufficient uterine contractions reached.

干预措施: Oxytocin (Drug)

placebo plus oxytocin

Placebo Comparator

121 control patients who will receive a similar capsule as a placebo (oxytocin plus placebo) before beginning induction.

干预措施: placebo (Drug)

placebo plus oxytocin

Placebo Comparator

121 control patients who will receive a similar capsule as a placebo (oxytocin plus placebo) before beginning induction.

干预措施: Oxytocin (Drug)

结局指标

主要结局

duration of first stage of labour

时间窗: 24 hours

duration of first stage of labour in hours

次要结局

  • rate of cesarean section(48 hours)
  • Apgar score(24 hours)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Amr Ahmed Mahmoud Riad

Lecturer of obstetrics and gynecology

Ain Shams Maternity Hospital

研究点 (1)

Loading locations...

相似试验

The Effect of Coadministration of Oral Propranolol... | 临床试验